This is for the inspection carried out by them at Aleor Dermaceuticals’ formulation facility at Karakhadi, Gujarat during the period from February 4, 2019 to February 8, 2019.

Dr. Reddy's Laboratories informed the bourses that it has launched Testosterone Gel 1.62 per cent, a therapeutic equivalent generic version of AndroGel (testosterone gel) 1.62 per cent, approved by USFDA.

Ducon Infratechnologies has received a FGD project order from Chloride Metals. 

The US drug regulator has as classified Strides' Puducherry facility under the Official Action Initiated (OAI) category, the company informed in a press release.

Eyeing a bigger market share in the packaged fruit and juice segment, ITC has launched three new variants under its product ‘B Natural’, which is into fruit beverages.

Morepen Labs reported a steep 125 per cent rise in its net profit at Rs. 9.22 crore from Rs. 4.11 crore in YoY and a 31 per cent rise in its total revenue at Rs. 207.1 crore in the quarter ended March 2019 as against Rs. 158.34 crore.

Overall volumes in futures & options currently stand at 97.24 lakh contracts with a turnover of Rs.  6,44,850.26 crore.

Overall volumes in futures & options currently stand at 97.24 lakh contracts with a turnover of Rs.  6,44,850.26 crore.

The level of 11,650 is likely to act as a strong support and, on the flip-side, the level of 11,800 may act as a resistance level for the Nifty. With this narrow trading zone, the Bollinger Bands are contracted and any close below the 11,650 level will lead to 11,550 level once again. Stocks that will be in focus include BRNL, Torrent, HIL, Yes Bank and Cadila Healthcare.

SGX Nifty was trading down by 60 points at 11,701 level, which clearly indicates that the domestic markets may witness selling pressure at the start of the week. Bharti Airtel, ICICI Bank and Marico are some of the key results scheduled for the day. Traders will also look forward to Nikkei India PMI service data for April which will be released later on Monday.